| pubmed-article:21143299 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C0582802 | lld:lifeskim |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C0041484 | lld:lifeskim |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C0376613 | lld:lifeskim |
| pubmed-article:21143299 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:21143299 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21143299 | pubmed:dateCreated | 2011-1-12 | lld:pubmed |
| pubmed-article:21143299 | pubmed:abstractText | Malignant melanoma of dogs is a highly aggressive neoplasm and is the 2nd most common digit tumor. Metastatic disease is a common sequela for which few effective treatment options exist. Studies show that xenogeneic tyrosinase DNA vaccination yields immune responses and prolongation of survival in dogs with oral malignant melanoma. | lld:pubmed |
| pubmed-article:21143299 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21143299 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21143299 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21143299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21143299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21143299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21143299 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21143299 | pubmed:issn | 1939-1676 | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:BergmanP JPJ | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:WolchokJ DJD | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:BartidoSS | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:LeibmanN FNF | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:ManleyC ACA | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:CraftD MDM | lld:pubmed |
| pubmed-article:21143299 | pubmed:author | pubmed-author:RivièreI CIC | lld:pubmed |
| pubmed-article:21143299 | pubmed:copyrightInfo | Copyright © 2010 by the American College of Veterinary Internal Medicine. | lld:pubmed |
| pubmed-article:21143299 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21143299 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:21143299 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21143299 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21143299 | pubmed:pagination | 94-9 | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:meshHeading | pubmed-meshheading:21143299... | lld:pubmed |
| pubmed-article:21143299 | pubmed:articleTitle | Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs. | lld:pubmed |
| pubmed-article:21143299 | pubmed:affiliation | Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY, USA. cmanley@theoncologyservice.com | lld:pubmed |
| pubmed-article:21143299 | pubmed:publicationType | Journal Article | lld:pubmed |
